Search / Trial NCT06233968

Using Data Science To Center Patient Perspectives in Mechanism Discovery

Launched by CAMBRIDGE HEALTH ALLIANCE · Jan 23, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

Natural Language Processing Machine Learning Internal Family Systems

ClinConnect Summary

This clinical trial is studying how to better understand and improve therapy for people with Posttraumatic Stress Disorder (PTSD) and Complex PTSD. The researchers believe that listening to patients' experiences can help develop new treatment methods. They will use advanced computer techniques, like natural language processing and deep learning, to analyze interviews with patients who are participating in an online group therapy program called PARTS, which is based on a therapy approach known as Internal Family Systems (IFS). By doing this, they hope to identify how therapy helps bring about psychological change.

To join the study, participants should be enrolled in the PARTS therapy program and have the ability to understand and communicate in English. They will need access to the internet and a device to participate in online assessments and interviews. Participants will complete questionnaires and have two video interviews—one at the beginning of the study and another a few weeks after finishing the therapy. This study is currently looking for individuals aged 18 and older, and it’s important to note that some people may not be eligible if they have certain medical conditions or if they are expecting to be hospitalized or incarcerated soon. Overall, this trial aims to put patients' perspectives at the heart of understanding how therapy can effect change.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Must be enrolled in the clinical service offering online PARTS group and approved and confirmed to start by the clinical team.
  • Have sufficient English fluency and literacy skills to understand the consent process, procedures and questionnaires and have the ability to provide written informed consent.
  • Have access to the internet and an electronic device with adequate data capacity; to complete questionnaires online and participate in two online video interviews.
  • Must be willing to complete online computerized assessments both at baseline and post-intervention; and participate in two, one-hour videotaped interviews one at baseline and one 2-4 weeks post-intervention.
  • Exclusion Criteria:
  • Inability to complete an informed consent assessment AND/OR inability to complete baseline study assessment procedures (due to cognitive deficit, non-proficiency in English literacy, or any other reason).
  • Expected medical hospitalization in 24 weeks from the date of enrollment.
  • Expected incarceration in 24 weeks from the date of enrollment.
  • Individuals who are pregnant with a due date within 24 weeks after study consent.
  • Insufficient internet connection to conduct online interviews or computerized assessments.

Trial Officials

Zev Schuman-Olivier, MD

Principal Investigator

Center for Mindfulness and Compassion, Cambridge Health Alliance

Dilara Ally, PhD

Principal Investigator

Center for Mindfulness and Compassion, Cambridge Health Alliance

About Cambridge Health Alliance

Cambridge Health Alliance (CHA) is a prominent healthcare system in Massachusetts, dedicated to providing high-quality, community-centered health services. As a clinical trial sponsor, CHA leverages its robust research infrastructure and commitment to innovation to advance medical knowledge and improve patient outcomes. With a focus on diverse populations, CHA conducts clinical trials across various therapeutic areas, ensuring that research is inclusive and reflective of the community it serves. The organization is committed to ethical standards and regulatory compliance, fostering collaboration among healthcare professionals, researchers, and participants to drive advancements in clinical care.

Locations

Malden, Massachusetts, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0